Investors looking for high-quality stocks that offer steady growth in earnings, low debt and high returns on equity can benefit from Barclays Screen, which revealed nearly three dozen such names. All told, 33 stocks made high-quality cuts for Barclays, naming a total of 11 industrial, 10 technology, six consumer discretionary, four healthcare and two consumer staples. Each stock on the list is rated overweight by a British bank. MercadoLibre, a Latin American online retailer traded on the Nasdaq, turns up as one of six recommended consumer discretionary stocks, with the biggest jump of them all (97% at the start of the week) relative to Barclays analysts’ price targets. is one. , It has an estimated return on equity of 32% for 2022. IDEXX Laboratories, a Nasdaq 100-listed pet health care provider, is one of four health care stocks that made the cut at Barclays. It is also the one offering the highest potential upside in the group at 89%, and has a 2022 ROE of 67%. Ferguson, a British-based plumbing and heating products maker whose primary listing moved to the New York Stock Exchange in March, is one of 11 industrial companies — the most of any sector — on the list and the biggest upside for the bank. . Price target, at 64%, with an estimated ROE of 41%. Pure Storage, an all-flash data storage hardware and software maker, has the highest potential return of 10 technology stocks on Barclays’ list, at 62% and an ROE of 29%. Flooring retailer Floor & Decor is another consumer-discretionary company, with a potential upside of 53% and an ROE of 21%. —CNBC’s Michael Bloom contributed to this report.
